|
|
Article: Research and Markets: This Essential Report on Cancer Drug Resistance is Available Now.
- Article from:
- Business Wire
- Article date:
- September 17, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/1e8682/cancer_drug_resist) has announced the addition of the "Cancer Drug Resistance" report to their offering.
Resistance mechanisms, resistance biomarkers, current & pipeline cancer drugs and strategies to combat drug resistance
A detailed and comprehensive review of cancer drug resistance
Drug resistance is the single most important cause of cancer treatment failure and carries a massive burden to patients, healthcare providers, drug developers and society. It is estimated that Multidrug Resistance (MDR) plays a major role in up to 50% of cancer cases. Today, ...